MedPath
NMPA Approval

Ligustrazine Hydrochloride Injection

国药准字H20058128

February 5, 2024

Drug Information

盐酸川芎嗪注射液

注射剂

2ml:40mg

化学药品

February 5, 2024

Company Information

Applicant Company

南阳市镇平工业园区

Manufacturing Company

南阳市镇平工业园区

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

盐酸川芎嗪注射液 - NMPA 批准文号 | MedPath